State of Illinois v. CSL PLASMA, INC.

CourtDistrict Court, N.D. Illinois
DecidedOctober 18, 2022
Docket1:20-cv-03535
StatusUnknown

This text of State of Illinois v. CSL PLASMA, INC. (State of Illinois v. CSL PLASMA, INC.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State of Illinois v. CSL PLASMA, INC., (N.D. Ill. 2022).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

STATE OF ILLINOIS,

Plaintiff, Case No. 20-CV-3535 v. Judge Mary M. Rowland CSL PLASMA, INC. AND CSL BEHRING, LLC,

Defendants.

MEMORANDUM OPINION AND ORDER

Plaintiff State of Illinois sues Defendants CSL Plasma, Inc. and CSL Behring, LLC, operators of blood plasma collection centers, for discriminating against people with disabilities in violation of Title III of the Americans with Disabilities Act (ADA) and the Illinois Human Rights Act (IHRA). Both statutes prohibit disability-based discrimination in “places of public accommodation,” including in any “service establishments.” Plaintiff moves now for partial summary judgment on the discrete legal issue of whether Defendants’ blood plasma collection centers constitute such “service establishments.” [76]; [77]. For the reasons explained below, this Court grants Plaintiff’s motion and concludes that Defendants’ collection centers qualify as “service establishments,” and thus “places of public accommodation” under both Acts. SUMMARY JUDGMENT STANDARD Summary judgment is proper where “the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a); see also Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986). A genuine dispute as to any material fact exists if “the evidence is such that a reasonable jury could return a verdict for the nonmoving party.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986). The substantive law controls which facts

are material. Id. After a “properly supported motion for summary judgment is made, the adverse party ‘must set forth specific facts showing that there is a genuine issue for trial.’” Id. at 250 (quoting Fed. R. Civ. P. 56(e)). The Court “consider[s] all of the evidence in the record in the light most favorable to the non-moving party, and [ ] draw[s] all reasonable inferences from that evidence in favor of the party opposing summary judgment.” Logan v. City of Chicago,

4 F.4th 529, 536 (7th Cir. 2021) (quotation omitted). The Court “must refrain from making credibility determinations or weighing evidence.” Viamedia, Inc. v. Comcast Corp., 951 F.3d 429, 467 (7th Cir. 2020) (citing Anderson, 477 U.S. at 255). In ruling on summary judgment, the Court gives the non-moving party “the benefit of reasonable inferences from the evidence, but not speculative inferences in [its] favor.” White v. City of Chicago, 829 F.3d 837, 841 (7th Cir. 2016) (internal citations omitted). “The controlling question is whether a reasonable trier of fact could find in favor of

the non-moving party on the evidence submitted in support of and opposition to the motion for summary judgment.” Id. BACKGROUND This Court takes the following facts from Plaintiff’s statement of facts [80], Defendants’ response to Plaintiff’s statement of facts [87], Defendant’s statement of additional facts [88], and Plaintiff’s response to Defendant’s statement of additional facts [92]. I. Parties

Plaintiff State of Illinois is a sovereign state of the United States of America. [80] ¶ 1. Its Attorney General Kwame Raoul brings this suit pursuant to the IHRA. Id. Defendant CSL Plasma, Inc. is an international corporation that collects source plasma from donors for use in pharmaceutical products. Id. ¶ 2. CSL Plasma is wholly owned by Defendant CSL Behring, LLC. Id. ¶3. CSL Plasma provides source plasma collected from donors to its parent CSL Behring, which then manufactures the source

plasma into plasma-derived medicinal products. Id. ¶ 4. CSL Behring then sells the resulting plasma-derived medicinal products in countries around the world for profit. Id. ¶ 7. II. Source Plasma Collection

Source plasma is human plasma collected via a process called “apheresis,” where a donor gives whole blood, a collector separates the plasma from other blood components, and the remaining blood components transfuse back into the donor. Id. ¶ 8. The Food and Drug Administration (FDA) heavily regulates collection of source plasma for use in plasma-derived medicinal products. Id. ¶ 9. Source plasma can only be legally obtained through apheresis, and source plasma collection can only legally occur in a properly equipped and regulated facility like CSL Plasma’s collection centers. Id. ¶¶ 10–11. CSL Plasma operates more than three hundred donation centers in the United States and around the world. Id. ¶ 13. CSL Plasma currently operates fourteen donation centers in Illinois and anticipates opening another three centers in the near

future. Id. ¶ 14. These donation centers sit within strip malls and other areas of commercial activity. Id. ¶ 15. A potential donor can arrive at one of CSL Plasma’s donation centers with or without an appointment. Id. ¶ 19; [87] ¶ 19. A potential donor need not pay to attempt to donate or to donate their plasma. [80] ¶ 20. A potential donor also need not provide proof of insurance or a special membership. Id. ¶ 21. Donors may donate twice in any seven day period as long as one day elapses

between their donations. [87] ¶ 29. Not all members of the public are eligible to donate plasma at CSL Plasma. [88] ¶ 15. CSL Plasma restricts potential donor based on age, weight, medical conditions, and the potential donor’s geographic radius to the donation center. Id. ¶ 15. Answers to medical history questions and a physical examination determine eligibility to donate. Id. ¶ 14. III. Compensation

Donors receive compensation for the time they spend donating plasma; CSL Plasma provides compensation via a debt card it provides. [80] ¶¶ 30, 31. On average, a donor earns $40.00 per donation. Id. ¶ 32. CSL Plasma also offers a rewards program through which donors can earn additional money by donating more frequently. Id. ¶ 33. From time to time, CSL Plasma also offers special promotions encouraging donors to donate more frequently, which can result in additional compensation. Id. ¶ 34. CSL Plasma also offers increased compensation for donors donating twice within a week to drive volume. Id. ¶ 36. CSL Plasma offers higher compensation to new donors, who receive $100.00 at the first donation and $125.00

at the second donation. Id. ¶ 37. Further, donors can receive additional compensation for donating a certain number of times in a year and for completing feedback surveys. Id. ¶ 38. Additionally, a donor may receive additional compensation for referring others who successfully make two donations. Id. IV. Procedural History

In June 2020, Plaintiff filed suit against Defendants under Title III of the Americans with Disabilities Act (ADA), and the Illinois Human Rights Act (IHRA), seeking to enjoin Defendants from refusing to serve individuals with disabilities at their collection centers. [1]. The complaint accuses CSL Plasma of preventing individuals with mental health disabilities who use a service animal or who are deaf from providing plasma and being compensated for their time, in violation of the ADA and the IHRA. Id. ¶¶ 3, 4. Plaintiff moves for partial summary judgment on the single issue of whether

CSL Plasma collection centers constitute “places of public accommodation” under the ADA and IHRA. [76]. Defendants oppose the motion. [86].

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
PGA Tour, Inc. v. Martin
532 U.S. 661 (Supreme Court, 2001)
Dean v. United States
556 U.S. 568 (Supreme Court, 2009)
Bryan D. Tourdot v. Rockford Health Plans, Inc.
439 F.3d 351 (Seventh Circuit, 2006)
Duffy v. Illinois Dept. of Human Rights
820 N.E.2d 1186 (Appellate Court of Illinois, 2004)
General Motors Corp. v. Pappas
950 N.E.2d 1136 (Illinois Supreme Court, 2011)
Levorsen v. Octapharma Plasma, Inc.
828 F.3d 1227 (Tenth Circuit, 2016)
Our Country Home Enterprises, Inc. v. Commissioner
855 F.3d 773 (Seventh Circuit, 2017)
Mark Silguero v. CSL Plasma, Incorporated
907 F.3d 323 (Fifth Circuit, 2018)
George Matheis, Jr. v. CSL Plasma Inc
936 F.3d 171 (Third Circuit, 2019)
United States v. Keith Melvin
948 F.3d 848 (Seventh Circuit, 2020)
Viamedia, Incorporation v. Comcast Corporation
951 F.3d 429 (Seventh Circuit, 2020)
Tom Reed v. Brex Inc.
8 F.4th 569 (Seventh Circuit, 2021)
Schneider National Leasing Inc v. United States
11 F.4th 548 (Seventh Circuit, 2021)
Mashallah, Inc v. West Bend Mutual Insurance Com
20 F.4th 311 (Seventh Circuit, 2021)
M.U. v. Team Illinois Hockey Club, Inc.
2022 IL App (2d) 210568 (Appellate Court of Illinois, 2022)
A.H. ex rel. Holzmueller v. Illinois High School Ass'n
881 F.3d 587 (Seventh Circuit, 2018)
White v. City of Chicago
829 F.3d 837 (Seventh Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
State of Illinois v. CSL PLASMA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-of-illinois-v-csl-plasma-inc-ilnd-2022.